Yep, rome wasn't built in a day...but all anyone has to do is read what the FDA's own trial results say about TSOI's incredible JadiCell IP alone right!
And beyond the 5 JadiCell IP's TSOI has another 50 IP's in their already jam-packed pipeline...many of which have already passed through Phase I studies and Phase II clinical trials.
So it's not like we're not going to be getting factual material catalysts on a regular basis over the next calendar year alone...some of which will truly be jaw dropping...based on TSOI's novel stem cell science!
I personally couldn't care less who believes/disbelieve the FDA facts unveiled to date. It makes no difference what exchange TSOI is currently trading on either...as any boutique investment firm can buy any OTC stock they like by simply holding a democratic vote amongst their board members on what covenants they're going to be guided by internally right!
That's why I keep saying the big boys will come if/when TSOI secures their already stated goal of a collaborative JadiCell partner right twister g'nite!
News 
Market Data 
Discover 
